Salmaan Sayeed

Mr. Salmaan Sayeed

USC CSI-Cancer
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
SSStephanie N Shishido
Stephanie N Shishido
SSSalmaan Sayeed
Salmaan Sayeed
GCGeorge Courcoubetis
George Courcoubetis
Hooman DjaladatHooman Djaladat
Hooman Djaladat
GMGus Miranda
Gus Miranda
JMJeremy Mason
Jeremy Mason
Urinary bladder cancer (BCa) is the 10th most frequent cancer in the world, most commonly found among the elderly population, and becomes highly lethal once cells have spread from the primary tumor to surrounding tissues and distant organs. Cystectomy, alone or with other treatments, is used to treat most BCa patients, as it offers the best chance of cure. However, even with curative intent, 29% of patients experience relapse of the cancer, 50% of which occur within the first year of surgery. This study aims to use the liquid biopsy to noninvasively detect disease and discover prognostic markers for disease progression. Using the third generation high-definition single cell assay (HDSCA3.0), 50 bladder cancer patient samples and 50 normal donor (ND) samples were analyzed for circulating rare events in the peripheral blood (PB), including circulating tumor cells (CTCs) and large extracellular vesicles (LEVs). Here, we show that (i) CTCs and LEVs are detected in the PB of BCa patients prior to cystectomy, (ii) there is a high heterogeneity of CTCs, and (iii) liquid biopsy analytes correlate with clinical data elements. We observed a significant difference in the incidence of rare cells and LEVs between BCa and ND samples (median of 74.61 cells/mL and 30.91 LEVs/mL vs. 34.46 cells/mL and 3.34 LEVs/mL, respectively). Furthermore, using classification models for the liquid biopsy data, we achieved a sensitivity of 78% and specificity of 92% for the identification of BCa patient samples. Taken together, these data support the clinical utility of the liquid biopsy in detecting BCa, as well as the potential for predicting cancer recurrence and survival post-cystectomy to better inform treatment decisions in BCa care.

18 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
SSStephanie N Shishido
Stephanie N Shishido
Alireza GhoreifiAlireza Ghoreifi
Alireza Ghoreifi
SSSalmaan Sayeed
Salmaan Sayeed
GCGeorge Courcoubetis
George Courcoubetis
AHAmy Huang
Amy Huang
Hooman DjaladatHooman Djaladat
Hooman Djaladat
Urothelial carcinomas (UCs) are a broad and heterogeneous group of malignancies, with the prevalence of upper tract urothelial carcinoma (UTUC) being rare, accounting for only 5–10% of total malignancies. There is a need for additional toolsets to assist the current clinical paradigm of care for patients with UTUC. As a non-invasive tool for the discovery of cancer-related biomarkers, the liquid biopsy has the potential to represent the complex process of tumorigenesis and metastasis. Herein, we show the efficacy of the liquid biopsy as a source of biomarkers for detecting UTUC. Using the third-generation high-definition single-cell assay (HDSCA3.0) workflow, we investigate liquid biopsy samples collected from patients with UTUC and normal donors (NDs) to provide critical information regarding the molecular and morphological characteristics of circulating rare events. We document several important findings from the liquid biopsy analysis of patients diagnosed with UTUC prior to surgery: (1) Large extracellular vesicles (LEVs) and circulating tumor cells (CTCs) are detectable in the peripheral blood. (2) The rare-event profile is highly heterogeneous. (3) Clinical data elements correlate with liquid biopsy analytes. Overall, this study provides evidence for the efficacy of the liquid biopsy in understanding the biology of UTUC with the future intent of informing clinical decision making, ultimately improving patient outcomes.

30 May 2025 in Head & Neck
Verified
Journal Article
Closed access
SSSalmaan Sayeed
Salmaan Sayeed
JJJustin Joseph
Justin Joseph
LSLuke Stanisce
Luke Stanisce
RRRicardo Ramirez
Ricardo Ramirez
AKAzita Khorsandi
Azita Khorsandi
MUMark L. Urken
Mark L. Urken

11 November 2025 in Head & Neck
Verified
Journal Article
Closed access
SSSalmaan Sayeed
Salmaan Sayeed
LSLuke Stanisce
Luke Stanisce
RRRicardo J. Ramirez
Ricardo J. Ramirez
SSSoo Yeon Sohn
Soo Yeon Sohn
AKAzita Khorsandi
Azita Khorsandi
MUMark L. Urken
Mark L. Urken